UC Davis Comprehensive Cancer Center at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

UC Davis Comprehensive Cancer Center brings 2 presentations to ISLB 2026 in Madrid. Its work centres on following lung and breast cancer over time with plasma tumour DNA, and on how molecular test results guide treatment. One focus is a case-based approach to molecular testing in advanced non-small cell lung cancer.

OrganizationISLB 2026 Attendance
health.ucdavis.edu
Hospitals & cancer centres
NCI-designated comprehensive cancer centre of the University of California, Davis, in Sacramento, California.
Session
Sat Nov 7
1:45pm–3:15pm
Stakeholder Workshop
Session
Sat Nov 7
4:00pm–5:30pm
Molecular Tumor Board
Clinical use
Talk
Sat Nov 7
4:00pm–5:30pm
Part of Molecular Tumor Board
Case-based Approach to Molecular Testing: Advanced NSCLC
Clinical use
Industry
Mon Nov 9
8:00am–9:00am
Part of From Plasma to Practice: Longitudinal Insights for Breast and Lung Cancer
Introductions to Technology and Longitudinal Monitoring
Industry hosted by Guardant Health
Clinical use · ctDNA & MRD

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from UC Davis Comprehensive Cancer Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction